Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep672 | Pituitary and Neuroendocrinology | ECE2022

Service evaluation of endocrine and surgical outcomes post-pituitary surgery for non-functioning pituitary macroadenomas (NFPAs) in a subset of patients

Ikegwu Rosemary , Mathad Nijaguna , Hempenstall Jonathan , Knysak Alicja , Al-Mrayat Ma'en

Background: Non-functioning pituitary adenomas (NFPAs) are the most common pituitary macroadenomas with a prevalence of 7-22 per 100,000 population. As they are non-secretory, they tend to present late with visual disturbances, headaches or hormonal deficiencies. Surgery is the main treatment for NFPAs, particularly endoscopic transsphenoidal surgery which can be associated with surgical and endocrine complications.Aims: To compare pre- and post-operativ...

ea0090p550 | Adrenal and Cardiovascular Endocrinology | ECE2023

Is there any link between non-classic adrenal hyperplasia (NCAH) and glucose metabolism?

Domagała Bartosz , Gamrat Aleksandra , Skalniak Anna , Przybylik-Mazurek Elwira , Trofimiuk-Muldner Malgorzata , Hubalewska-Dydejczyk Alicja

Introduction: There are data reporting an increased risk of cardiovascular and metabolic complications in patients with NCAH. This is frequently attributed to glucocorticoid (over)use. It seems that long-term exposure to increased androgens concentration may also itself lead to diminished insulin sensitivity and increased risk of prediabetes and diabetes.Aim: The aim of the study was to assess the link between NCAH diagnosis and glucose metabolism distur...

ea0090p303 | Calcium and Bone | ECE2023

SPECT/CT parathyroid scintigraphy in primary hyperparathyroidism: minimizing the risk of negative results by biochemical parameters assessment

Drynda Anna , Kucharczyk Karolina , Sokolowski Grzegorz , Trofimiuk-Muldner Malgorzata , Hubalewska-Dydejczyk Alicja

Primary hyperparathyroidism (PHP) diagnosis in clinical practice is based on biochemical blood tests. Since a single parathyroid adenoma causes about 85% of cases, the treatment of choice is parathyroidectomy, preceded by imaging studies. Ultrasound and [99mTc]sestamibi scanning can enable adenoma localization. However, the latter method is of higher sensitivity, especially if combined with anatomical imaging. In some cases, the radiotracer uptake in adenoma tissue ...

ea0090p387 | Endocrine-related Cancer | ECE2023

Don’t let your guard down – aggressive, hereditary paraganglioma associated with SDHD gene nonsense variant: c.33C>A (p.(Cys11Ter))

Szatko Alicja , Leszczynska Dorota , Woźniak Beata , Papierska Lucyna , Zgliczyński Wojciech , Glinicki Piotr

Introduction: Paragangliomas belong to the neuroendocrine tumours arising from autonomic nervous system. Various localizations, symptoms that can mimic a wide range of diseases and often unpredictable ability to metastasize are the reasons why paragangliomas pose a significant diagnostic challenge. More than one third of paragangliomas is associated with germline mutations –succinate dehydrogenase (SDH) subunit genes are among the most common susceptibility genes. SDHD wa...

ea0090p157 | Pituitary and Neuroendocrinology | ECE2023

Various cut-off points for paradoxical increase of growth hormone after glucose load in patients with acromegaly and their clinical implications

Godlewska Magdalena , Bogusławska Anna , Grochowska Anna , Hubalewska-Dydejczyk Alicja , Gilis-Januszewska Aleksandra

Introduction: Paradoxical increase of growth hormone after glucose load (PR) and its clinical significance remain the focus of researchers. Different cut off points for diagnosis of PR are used in the literature. Aim : Our aim was to investigate 3 different definitions of PR and their clinical implications.Material and Methods: We analyzed 116 consecutive patients diagnosed with acromegaly in 2012-2022. We included 89 patients with...

ea0090p168 | Pituitary and Neuroendocrinology | ECE2023

Quantitative assessment of the signal intensity of somatotropin pituitary tumors and its clinical implications in consecutive newly-diagnosed patients with acromegaly

Godlewska Magdalena , Bogusławska Anna , Grochowska Anna , Hubalewska-Dydejczyk Alicja , Gilis-Januszewska Aleksandra

Introduction: Somatotroph Pituitary Neuroendocrine Tumor’s (sPitNET) signal intensity in T2-weighted MR images (SI) was reported as prognostic marker for tumor’s aggressiveness and poor response to 1st generation somatostatin analogs (SSA). Tumors are arbitrary divided into 3 groups: hyperintensive (HYPER), isointensive (ISO) and hypointensive (HYPO). Aim: Our aim was to quantitatively assess SI of sPitNETs and investigate its clinic...

ea0090p169 | Pituitary and Neuroendocrinology | ECE2023

Lymphocytic Hypophysitis – many faces of the same disesase. Watchful waiting could be suggested therapeutic approach in majority of patients

Kluczyński Łukasz , Godlewska Magdalena , Hubalewska-Dydejczyk Alicja , Gilis-Januszewska Aleksandra

Introduction: Clinical manifestation of hypophysitis depends on presence of hormonal abnormalities and/or enlargement of pituitary structures. Both the diagnosis and treatment still remain challenging. Hormonal replacement is the basic therapy, while steroids are the first-line treatment in case of mass related symptoms. The course of the disease varies from spontaneous remission to atrophy of the pituitary gland.Aim: To characterize and sum up clinical/...

ea0090ep69 | Adrenal and Cardiovascular Endocrinology | ECE2023

Effects of Osilodrostat and Metyrapone on steroidogenesis in adrenocortical H295R tumor cells in vitro

Thomeret Louis , Berthon Annabel , Perlemoine Karine , Poirier Jonathan , Blanchet Benoit , Puszkiel Alicja , Bertherat Jerome , Fideline Bonnet

Introduction: Osilodrostat and Metyrapone are two CYP11B1 inhibitors used for the treatment of patients with Cushing syndrome. Despite their common suspected mechanism of action, the comparison of serum steroid profiles determined in HPLC-MS/MS in patients treated by either Osilodrostat or Metyrapone for an ACTH-dependent Cushing syndrome identified higher levels of 11-deoxycortisol and androgens in patients treated by Metyrapone than in those treated by Osilodrostat (F. B...

ea0090ep673 | Pituitary and Neuroendocrinology | ECE2023

Hyponatraemia post endoscopic pituitary surgery: A tertiary centre experience of a large cohort

Knysak Alicja , Mathad Nijaguna , Hempenstall Jonathan , Bujanova Jana , Al-Mrayat Ma'en

Post-pituitary surgery hyponatraemia (HN, sodium <135 mmol/l) is relatively common and may result in prolonged hospitalisation. Herein we report a retrospective analysis of our experience in a tertiary institute. We conducted a retrospective case note review of 318 patients (M 54%, F 46%, mean age 58 years) 65.7% non-functioning adenoma (NFA), 10% somatotropinoma, 5% prolactinoma, 11% corticotropinoma (half were clinically silent), 8% craniopharyngioma, an...

ea0090ep1009 | Thyroid | ECE2023

50 Shades of Graves’

Newland-Jones Philip , Bujanova Jana , Pilobello Nemia , Bray Diane , Knysak Alicja

Introduction: We present a series of 10 cases of GD presenting with seemingly unrelated symptoms with limited features of thyrotoxicosis, where control of thyroid function tests (TFTs) led to complete normalisation of presenting symptoms. In all cases patients were shown to have Graves disease with thyroid antibodies.Case series review: 1. 82F with symptomatic hypercalcaemia and thymic hyperplasia on CT. Calcium normalised with standard therapy and remai...